Laserfiche WebLink
5. Provide training to health care providers who work with pregnant or parenting women on best <br />practices for compliance with federal requirements that children born with Neonatal Abstinence <br />Syndrome get referred to appropriate services and receive a plan of safe care. <br />6. Child and family supports for parenting women with OUD and any co-occurring SUD/MH <br />conditions. <br />7. Enhanced family supports and child care services for parents with OUD and any co-occurring <br />SUD/MH conditions. <br />8. Provide enhanced support for children and family members suffering trauma as a result of addiction <br />in the family; and offer trauma -informed behavioral health treatment for adverse childhood events. <br />9. Offer home-based wrap-around services to persons with OUD and any co-occurring SUD/MH <br />conditions, including but not limited to parent skills training. <br />10. Support for Children's Services — Fund additional positions and services, including supportive <br />housing and other residential services, relating to children being removed from the home and/or placed <br />in foster care due to custodial opioid use. <br />PART TWO: PREVENTION <br />F. PREVENT OVER -PRESCRIBING AND ENSURE APPROPRIATE PRESCRIBING AND <br />DISPENSING OF OPIOIDS <br />Support efforts to prevent over -prescribing and ensure appropriate prescribing and dispensing of <br />opioids through evidence -based or evidence -informed programs or strategies that may include, but are <br />not limited to, the following: <br />1. Fund medical provider education and outreach regarding best prescribing practices for opioids <br />consistent with Guidelines for Prescribing Opioids for Chronic Pain from the U.S. Centers for Disease <br />Control and Prevention, including providers at hospitals (academic detailing). <br />2. Training for health care providers regarding safe and responsible opioid prescribing, dosing, and <br />tapering patients off opioids. <br />3. Continuing Medical Education (CME) on appropriate prescribing of opioids. <br />4. Support for non -opioid pain treatment alternatives, including training providers to offer or refer to <br />multi -modal, evidence -informed treatment of pain. <br />5. Support enhancements or improvements to Prescription Drug Monitoring Programs (PDMPs), <br />including but not limited to improvements that: <br />a. Increase the number of prescribers using PDMPs; <br />b. Improve point -of -care decision-making by increasing the quantity, quality, or format of data <br />available to prescribers using PDMPs, by improving the interface that prescribers use to access <br />PDMP data, or both; or <br />8 <br />